Literature DB >> 30692607

Prioritizing Crohn's disease genes by integrating association signals with gene expression implicates monocyte subsets.

Kyle Gettler1, Mamta Giri2, Ephraim Kenigsberg2, Jerome Martin2, Ling-Shiang Chuang2, Nai-Yun Hsu2, Lee A Denson3, Jeffrey S Hyams4, Anne Griffiths5, Joshua D Noe6, Wallace V Crandall7, David R Mack8, Richard Kellermayer9, Clara Abraham10, Gabriel Hoffman2, Subra Kugathasan11,12, Judy H Cho13,14.   

Abstract

Genome-wide association studies have identified ~170 loci associated with Crohn's disease (CD) and defining which genes drive these association signals is a major challenge. The primary aim of this study was to define which CD locus genes are most likely to be disease related. We developed a gene prioritization regression model (GPRM) by integrating complementary mRNA expression datasets, including bulk RNA-Seq from the terminal ileum of 302 newly diagnosed, untreated CD patients and controls, and in stimulated monocytes. Transcriptome-wide association and co-expression network analyses were performed on the ileal RNA-Seq datasets, identifying 40 genome-wide significant genes. Co-expression network analysis identified a single gene module, which was substantially enriched for CD locus genes and most highly expressed in monocytes. By including expression-based and epigenetic information, we refined likely CD genes to 2.5 prioritized genes per locus from an average of 7.8 total genes. We validated our model structure using cross-validation and our prioritization results by protein-association network analyses, which demonstrated significantly higher CD gene interactions for prioritized compared with non-prioritized genes. Although individual datasets cannot convey all of the information relevant to a disease, combining data from multiple relevant expression-based datasets improves prediction of disease genes and helps to further understanding of disease pathogenesis.

Entities:  

Mesh:

Year:  2019        PMID: 30692607      PMCID: PMC7446136          DOI: 10.1038/s41435-019-0059-y

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  67 in total

1.  The influence of infliximab and adalimumab on the expression of apoptosis-related proteins in lamina propria mononuclear cells and enterocytes in Crohn's disease - an immunohistochemical study.

Authors:  Piotr Eder; Liliana Lykowska-Szuber; Iwona Krela-Kazmierczak; Kamila Stawczyk-Eder; Maciej Zabel; Krzysztof Linke
Journal:  J Crohns Colitis       Date:  2012-09-27       Impact factor: 9.071

2.  Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.

Authors:  David A van Heel; Subrata Ghosh; Matt Butler; Karen A Hunt; Anna M C Lundberg; Tariq Ahmad; Dermot P B McGovern; Clive Onnie; Kenichi Negoro; Sue Goldthorpe; Brian M J Foxwell; Christopher G Mathew; Alastair Forbes; Derek P Jewell; Raymond J Playford
Journal:  Lancet       Date:  2005 May 21-27       Impact factor: 79.321

3.  A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3.

Authors:  Aditya Murthy; Yun Li; Ivan Peng; Mike Reichelt; Anand Kumar Katakam; Rajkumar Noubade; Merone Roose-Girma; Jason DeVoss; Lauri Diehl; Robert R Graham; Menno van Lookeren Campagne
Journal:  Nature       Date:  2014-02-19       Impact factor: 49.962

4.  Changes in chemokines and their receptors in blood during treatment with the TNF inhibitor infliximab in patients with rheumatoid arthritis.

Authors:  C Eriksson; S Rantapää-Dahlqvist; K G Sundqvist
Journal:  Scand J Rheumatol       Date:  2013-02-05       Impact factor: 3.641

5.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

6.  Fine-mapping inflammatory bowel disease loci to single-variant resolution.

Authors:  Hailiang Huang; Ming Fang; Luke Jostins; Maša Umićević Mirkov; Gabrielle Boucher; Carl A Anderson; Vibeke Andersen; Isabelle Cleynen; Adrian Cortes; François Crins; Mauro D'Amato; Valérie Deffontaine; Julia Dmitrieva; Elisa Docampo; Mahmoud Elansary; Kyle Kai-How Farh; Andre Franke; Ann-Stephan Gori; Philippe Goyette; Jonas Halfvarson; Talin Haritunians; Jo Knight; Ian C Lawrance; Charlie W Lees; Edouard Louis; Rob Mariman; Theo Meuwissen; Myriam Mni; Yukihide Momozawa; Miles Parkes; Sarah L Spain; Emilie Théâtre; Gosia Trynka; Jack Satsangi; Suzanne van Sommeren; Severine Vermeire; Ramnik J Xavier; Rinse K Weersma; Richard H Duerr; Christopher G Mathew; John D Rioux; Dermot P B McGovern; Judy H Cho; Michel Georges; Mark J Daly; Jeffrey C Barrett
Journal:  Nature       Date:  2017-06-28       Impact factor: 49.962

7.  Human LACC1 increases innate receptor-induced responses and a LACC1 disease-risk variant modulates these outcomes.

Authors:  Amit Lahiri; Matija Hedl; Jie Yan; Clara Abraham
Journal:  Nat Commun       Date:  2017-06-08       Impact factor: 14.919

8.  A flexible and accurate genotype imputation method for the next generation of genome-wide association studies.

Authors:  Bryan N Howie; Peter Donnelly; Jonathan Marchini
Journal:  PLoS Genet       Date:  2009-06-19       Impact factor: 5.917

9.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

10.  Genetic Complexity of Crohn's Disease in Two Large Ashkenazi Jewish Families.

Authors:  Adam P Levine; Nikolas Pontikos; Elena R Schiff; Luke Jostins; Doug Speed; Laurence B Lovat; Jeffrey C Barrett; Helmut Grasberger; Vincent Plagnol; Anthony W Segal
Journal:  Gastroenterology       Date:  2016-07-01       Impact factor: 22.682

View more
  5 in total

1.  A myeloid-stromal niche and gp130 rescue in NOD2-driven Crohn's disease.

Authors:  Shikha Nayar; Joshua K Morrison; Mamta Giri; Kyle Gettler; Ling-Shiang Chuang; Laura A Walker; Huaibin M Ko; Ephraim Kenigsberg; Subra Kugathasan; Miriam Merad; Jaime Chu; Judy H Cho
Journal:  Nature       Date:  2021-03-31       Impact factor: 69.504

2.  Whole-Genome DNA Methylation Profiling of CD14+ Monocytes Reveals Disease Status and Activity Differences in Crohn's Disease Patients.

Authors:  Andrew Y F Li Yim; Nicolette W Duijvis; Mohammed Ghiboub; Catriona Sharp; Enrico Ferrero; Marcel M A M Mannens; Geert R D'Haens; Wouter J de Jonge; Anje A Te Velde; Peter Henneman
Journal:  J Clin Med       Date:  2020-04-08       Impact factor: 4.241

3.  Zebrafish modeling of intestinal injury, bacterial exposures and medications defines epithelial in vivo responses relevant to human inflammatory bowel disease.

Authors:  Ling-Shiang Chuang; Joshua Morrison; Nai-Yun Hsu; Philippe Ronel Labrias; Shikha Nayar; Ernie Chen; Nicole Villaverde; Jody Ann Facey; Gilles Boschetti; Mamta Giri; Mireia Castillo-Martin; Tin Htwe Thin; Yashoda Sharma; Jaime Chu; Judy H Cho
Journal:  Dis Model Mech       Date:  2019-08-13       Impact factor: 5.758

Review 4.  Reaching the End-Game for GWAS: Machine Learning Approaches for the Prioritization of Complex Disease Loci.

Authors:  Hannah L Nicholls; Christopher R John; David S Watson; Patricia B Munroe; Michael R Barnes; Claudia P Cabrera
Journal:  Front Genet       Date:  2020-04-15       Impact factor: 4.599

Review 5.  Interpretation of the role of germline and somatic non-coding mutations in cancer: expression and chromatin conformation informed analysis.

Authors:  Michael Pudjihartono; Jo K Perry; Cris Print; Justin M O'Sullivan; William Schierding
Journal:  Clin Epigenetics       Date:  2022-09-28       Impact factor: 7.259

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.